BIDMC study suggests worsening trends in back pain management

Improving the treatment of back pain could cut health care spending and better quality of care

2013-07-30

(Press-News.org) BOSTON – Patient care could be enhanced and the health care system could see significant cost savings if health care professionals followed published clinical guidelines to manage and treat back pain, according to researchers at Beth Israel Deaconess Medical Center and published in the July 29 issue of JAMA Internal Medicine.

"Back pain treatment is costly and frequently includes overuse of treatments that are not supported by clinical guidelines, and that don't impact outcomes," says lead author John N. Mafi, MD, a fellow in the Division of General Medicine and Primary Care at BIDMC. "Improvements in the management of spine-related disease represent an area of potential for improving the quality of care and for potential cost savings for the health care system."

Americans spend approximately $86 billion annually on back or neck pain-related health issues. It is ranked as the fifth most common reason for doctor visits, which accounts for more than 10 percent of all appointments made with primary care physicians.

Lost productivity adds approximately another $20 billion per year. It is predicted that expenditures will continue to grow along with the rise of chronic back pain.

Published guidelines for routine back pain advise use of non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and physical therapy. Prior research shows that within three months of these treatments back pain usually resolves.

The guidelines, which have remained consistent since the 1990s, suggest the need for imaging or advanced treatments is typically unnecessary, as most cases of routine back pain improve with these conservative measures. Other discordant recommendations would include prescription of a narcotic or referral to a specialist, presumably for the consideration of a procedure.

However, if acute neurological compromise or other warning signs such as past history of malignancy are connected with the back pain, further steps can be taken to investigate.

The researchers identified 23,918 visits for spine problems, representing 73 million visits annually using nationally representative data from the National Ambulatory Medicare Care and National Hospital Ambulatory Care surveys between 1999-2010. They studied the changes in utilization of diagnostic imaging, physical therapy or referral to other physicians, and the use of medication when treating patients who complained of back pain or were diagnosed with back pain.

"We observed a significant rise in the frequency of treatments that are considered discordant with current guidelines including the use of advanced imaging, such as CT or MRI, referrals to other physicians (presumably for procedures or surgery), and the use of narcotics," says Mafi. "We also have observed a decline in the use of first-line medications such as NSAIDs or acetaminophen, but no change in referrals to physical therapy.

"Although opiate prescriptions increased markedly over this time period, we also observed lower odds of receiving narcotics among female, Black, Hispanic, and other race/ethnicity patients, which may signify the potential disparities in pain management that have also been noted previously."

Unnecessary treatment is not only expensive, but also can come with complications. A meta-analysis concluded that narcotics offer minimal benefit to relieve acute back pain and have no proven efficacy in treating chronic back pain. The data also revealed that 43 percent of the patients had concurrent substance abuse disorders. Researchers believe that the increase in narcotic prescriptions is connected with the rise of narcotic overdose deaths, which is creating a public health crisis.

The steady increase of doctors' request for advanced diagnostic imaging has become a concern as well.

Overuse of imaging may not result in immediate problems but exposure to ionizing radiation can lead to further health complications such as cancer, Mafi notes, adding a study that linked regions with higher MRI use found an increase in back surgeries, which can be a very costly process and require recovery time.

"Increased use of advanced imaging represents an area of particular concern" says senior author Bruce Landon, MD. "Early in the course of back pain, such imaging is almost always wasteful. Moreover, there are almost always some abnormalities, which increases the likelihood that a patient will undergo expensive spine surgery that might not improve their outcomes over the longer term."

"Despite numerous published national guidelines, management of routine back pain increasingly has relied on advanced diagnostic imaging, referrals to other physicians, and use of narcotics, with a concomitant decrease in NSAIDs or acetaminophen use and no change in physical therapy referrals. With healthcare cost soaring, improvements in the management of back pain represent an area of potential cost savings for the healthcare system while also improving the quality of care," says Mafi.

### In addition to Mafi and Landon, also of the Department of Health Care Policy at Harvard Medical School authors include Ellen P. McCarthy, PhD, MPH and Roger B. Davis, ScD of BIDMC.

Mafi was supported by a NRSA training grant (T32HP12706) from the US Health Services and Research Administration. Davis was supported by the Harvard Catalyst (NIH Award #UL 1 RR 025758. No other disclosures were reported.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of Dana-Farber/Harvard Cancer Center.

BIDMC has a network of community partners that includes Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Anna Jaques Hospital, Lawrence General Hospital, Commonwealth Hematology-Oncology, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.

ELSE PRESS RELEASES FROM THIS DATE:

NIH researchers identify therapy that may curb kidney deterioration in patients with rare disorder

2013-07-30

A team led by researchers at the National Institutes of Health has overcome a major biological hurdle in an effort to find improved treatments for patients with a rare disease called methylmalonic acidemia (MMA). Using genetically engineered mice created for their studies, the team identified a set of biomarkers of kidney damage—a hallmark of the disorder—and demonstrated that antioxidant therapy protected kidney function in the mice. Researchers at the National Human Genome Research Institute (NHGRI), part of NIH, validated the same biomarkers in 46 patients with MMA ...

NIH math model predicts effects of diet, physical activity on childhood weight

2013-07-30

Researchers at the National Institutes of Health have created and confirmed the accuracy of a mathematical model that predicts how weight and body fat in children respond to adjustments in diet and physical activity. The results will appear online July 30 in The Lancet Diabetes and Endocrinology. While the model may help to set realistic expectations, it has not been tested in a controlled clinical trial to determine if it is an effective tool for weight management. The model evolved from one developed at the NIH in 2011 to predict weight change in adults. The model ...

Social amoebae travel with a posse

2013-07-30

In 2011, Nature announced that scientists had discovered a single-celled organism that is a primitive farmer. The organism, a social amoeba called Dictyostelium discoideum, picks up edible bacteria, carries them to new locations and harvests them like crops. D. discoideum enjoyed a brief spell in the media spotlight, billed as the world's smallest farmer. Now a collaboration of scientists at Washington University in St. Louis and Harvard University has taken a closer look at one lineage, or clone, of a D. discoideum farmer. This farmer carries not one but two strains ...

Understanding why male mammals choose monogamy

2013-07-30

In perhaps the most comprehensive and definitive effort to date, scientists have explained the processes that drove male mammals to adopt social monogamy as a breeding strategy. Because male mammals have a much higher potential to produce offspring in a single breeding season than do their female counterparts (who must endure long gestation periods), it would seem that mating with one female per cycle would be limiting. Yet a percentage of mammalian males do this -- and researchers have debated why, seeking to identify selective advantages social monogamy offers, for ...

Natural affinities -- unrecognized until now -- may have set stage for life to ignite

2013-07-30

The chemical components crucial to the start of life on Earth may have primed and protected each other in never-before-realized ways, according to new research led by University of Washington scientists. It could mean a simpler scenario for how that first spark of life came about on the planet, according to Sarah Keller, UW professor of chemistry, and Roy Black, UW affiliate professor of bioengineering, both co-authors of a paper published online July 29 in the Proceedings of the National Academy of Sciences. Scientists have long thought that life started when the right ...

New modular vaccine design combines best of existing vaccine technologies

2013-07-30

Boston, Mass.—A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination. The method, pioneered by researchers at Boston Children's Hospital, permits rapid construction of new vaccines that activate mulitple arms of the immune system simultaneously against one or more pathogens, generating robust immune protection with a lower risk of adverse effects. As reported by Fan Zhang, PhD, Ying-Jie Lu, PhD, and Richard Malley, MD, from ...

Capturing black hole spin could further understanding of galaxy growth

2013-07-30

Astronomers have found a new way of measuring the spin in supermassive black holes, which could lead to better understanding about how they drive the growth of galaxies. The scientists at Durham University, UK, observed a black hole - with mass 10 million times that of our Sun - at the centre of a spiral galaxy 500 million light years from Earth while it was feeding on the surrounding disc of material that fuels its growth and powers its activity. By viewing optical, ultra-violet and soft x-rays generated by heat as the black hole fed, they were able to measure how ...

Could sleeping stem cells hold key to treatment of aggressive blood cancer?

2013-07-30

Scientists studying an aggressive form of leukaemia have discovered that rather than displacing healthy stem cells in the bone marrow as previously believed, the cancer is putting them to sleep to prevent them forming new blood cells. The finding offers the potential that these stem cells could somehow be turned back on, offering a new form of treatment for the condition, called Acute Myeloid Leukaemia (AML). The work was led by scientists at Queen Mary, University of London with the support of Cancer Research UK's London Research Institute. Around 2,500* people are diagnosed ...

Pulsating star sheds light on exoplanet

2013-07-30

A team of researchers has devised a way to measure the internal properties of stars—a method that offers more accurate assessments of their orbiting planets. The research, which appears in Proceedings of the National Academy of Sciences, was conducted by a multi-national team of scientists, including physicists at New York University, Princeton University, and the Max Planck Institute for Solar System Research. The researchers examined HD 52265—a star approximately 92 light years away and nearly 20 percent more massive than our Sun. More than a decade ago, scientists ...

Essential clue to Huntington's disease solution found by McMaster researchers

2013-07-30

Hamilton, ON -- Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD). HD is a brain disease that can affect 1 in about 7,000 people in mid-life, causing an increasing loss of brain cells at the centre of the brain. HD researchers have known what the exact DNA change is that causes Huntington's disease since 1993, but what is typically seen in patients does not lead to disease in animal models. This has made drug discovery difficult. In this week's issue of the science journal, the Proceedings of ...

BIDMC study suggests worsening trends in back pain management

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: